đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is a Phase 3, randomized, modified double-blind study which aims...
Status
Active Not Recruiting
Location
Investigational Site Number : 0560004
Start Date
2025-05-22
Trial ID
NCT06975878
Treatments Being Tested
The primary objective is to evaluate V114 in the prevention of vaccine-type...
Status
Completed
Location
Chulalongkorn University ( Site 0008)
Start Date
2020-09-12
Trial ID
NCT04193215
Treatments Being Tested
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Hvidovre Hospital ( Site 0003)
Start Date
2019-08-28
Trial ID
NCT04016714
Treatments Being Tested
The purpose of this study is to assess how well-tolerated GSK's investigati...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-11-26
Trial ID
NCT06693895
The purpose of this clinical study is to evaluate the safety and immunogeni...
Status
Completed
Location
Morinaga Maternity Clinic ( Site 3345)
Start Date
2020-07-01
Trial ID
NCT04384107
The purpose of this study is 1) to evaluate the safety and tolerability of ...
Status
Completed
Location
Tampereen yliopisto Espoon rokotetutkimusklinikka ( Site 0007)
Start Date
2019-06-25
Trial ID
NCT03885934
Treatments Being Tested
The purpose of this study is to evaluate the immune response and safety of ...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-05-15
Trial ID
NCT06806137
The purpose of this study is to assess the consistency of immune response t...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2025-01-10
Trial ID
NCT06740630
This is a study of V114 in children infected with HIV. Participants will be...
Status
Completed
Location
Perinatal HIV Research Unit ( Site 0042)
Start Date
2019-11-05
Trial ID
NCT03921424
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested